Found: 3
Select item for more details and to access through your institution.
Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2011, v. 34, n. 8, p. 911, doi. 10.1111/j.1365-2036.2011.04827.x
- By:
- Publication type:
- Article
Search for Factor V Arg[sup 306] Cambridge and Hong Kong Mutations in Mixed Hungarian Population Samples.
- Published in:
- Acta Haematologica, 2003, v. 110, n. 4, p. 220, doi. 10.1159/000074233
- By:
- Publication type:
- Article
Plasma carnitine ester profiles in Crohn's disease and ulcerative colitis patients with different IGR2230a_1 genotypes.
- Published in:
- International Journal of Immunogenetics, 2009, v. 36, n. 6, p. 329, doi. 10.1111/j.1744-313X.2009.00834.x
- By:
- Publication type:
- Article